Vice-Chair, Research
Northwell School of Medicine and the Feinstein Institute for Medical Research
Halesite, NY
Dr. Deutschman is a graduate of Trinity College (BS), Northwestern (MS) and New York Medical College (MD). After flirtations with surgery/neurosurgery he trained in Surgical Critical Care (U. Minnesota) and Anesthesiology/Critical Care Medicine (Johns Hopkins). He was on the faculty at Hopkins (1988-1993) and the University of Pennsylvania (1993-2014) before joining Northwell Health/the Feinstein Institutes in 2014. At Penn he directed the Anesthesia Critical Care Fellowship and an NIH-funded Research Fellowship (T32) and received the Leonard Berwick Teaching Award
Dr. Deutschman’s sepsis research includes the Sepsis-3 definitions (JAMA 2016co-first and corresponding author). His NIH supported research focuses on how changes in the endocrine and neural systems alter function in the brain, heart, lung, liver and kidneys and cellular/sub-cellular changes in signal transduction and mitochondrial function. Dr. Deutschman has co-authored over 160 peer-reviewed publications and over 90 book chapters and editorials. He is co-editor, with Dr. Patrick Neligan, of “Evidenced – Based Practice of Critical Care” – (3rd edition released in Jan 2020).
Dr. Deutschman was President of the SCCM (2012) and the American Society of Critical Care Anesthesiologists (now SOCCA, 2002-4). He has reviewed for the NIH, the VA Merit system, the Wellcome Trust, the Irish Health Research Board and the Research Foundation-Flanders. He is Scientific Editor of Critical Care Medicine and serves on the editorial boards of several other journals. He has received the Lifetime Achievement Award from SOCCA and the designation MCCM from the American College of Critical Care Medicine.
Dr. Deutschman grew up in New York and, despite living “elsewhere” for many years, remained a hard-core New Yorker. He was elated to return to New York in 2014 after 35 years in exile. He roots for the NY Giants and Yankees, something he kept a closely guarded secret while living in Philadelphia.
Saturday, January 21, 2023
10:45 AM – 11:45 AM PT
Disclosure(s): Enlivex Inc: Consultant (Ongoing); La Jolla Pharmaceuticals: Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Ongoing)